CAS 2407529-33-1

Fórmula: C31H37F5N4O7

InChI: InChI=1S/C27H31F5N4O.C4H6O6/c1-16-9-20-19-5-2-3-6-23(19)34-25(20)26(36(16)14-27(31,32)15-37)24-21(29)10-17(11-22(24)30)33-18-12-35(13-18)8-4-7-28;5-1(3(7)8)2(6)4(9)10/h2-3,5-6,10-11,16,18,26,33-34,37H,4,7-9,12-15H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t16-,26-;1-,2-/m11/s1

Clave InChI: QZOTWXMHTSEIJY-WULFPPIKSA-N

SMILES: C[C@@H]1CC2=C([C@H](N1CC(CO)(F)F)C3=C(C=C(C=C3F)NC4CN(C4)CCCF)F)NC5=CC=CC=C25.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O

3-((1R,3R)-1-(2,6-Difluoro-4-((1-(3-fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol (2R,3R)-2,3-dihydroxysuccinate

CAS: 2407529-33-1

Fórmula: C₃₁H₃₇F₅N₄O₇

Pureza: 98%

Forma y color: Solid

Peso molecular: 672.6401

Ref: IN-DA01X6HZ

Giredestrant tartrate

CAS: 2407529-33-1

Giredestrant tartrate

Fórmula: C₃₁H₃₇F₅N₄O₇

Pureza: ≥95%

Peso molecular: 672.64

Ref: 54-BUP09151

Giredestrant tartrate

CAS: 2407529-33-1

Giredestrant tartrate: a new oral, selective non-steroidal ER antagonist, inhibits ER-mediated gene activation and degrades ER protein, treating tumors.

Fórmula: C₃₁H₃₇F₅N₄O₇

Pureza: 97.01%

Forma y color: Yellow Solid

Peso molecular: 672.64

Ref: TM-T11236